Поиск

Автор

Ключевое слово

Коллекция

Дополнительно:

Период публикации

Научный руководитель

Оппонент

По вашему запросу найдено документов: 192

Страница 5 из 20

CATALYTIC CYCLOMETALLATION IN STEROID CHEMISTRY III1 : SYNTHESIS OF STEROIDAL DERIVATIVES OF 5Z,9Z-DIENOIC ACID AND INVESTIGATION OF ITS HUMAN TOPOISOMERASE I INHIBITORY ACTIVITY

D’yakonov, V.A., Dzhemileva, L.U., Tuktarova, R.A., Makarov, A.A., Islamov, I.I., Mulyukova, A.R., Dzhemilev, U.M. (2015)

Topoisomerase I inhibitors

NZ,(N + 4)Z-DIENOIC FATTY ACIDS: A NEW METHOD FOR THE SYNTHESIS AND INHIBITORY ACTION ON TOPOISOMERASE I AND IIA

D’yakonov, Vladimir A., Dzhemileva, Lilya U., Makarov, Aleksey A., Mulyukova, Alfiya R., Baev, Dmitry S., Khusnutdinova, Elza K., Tolstikova, Tatiana G., Dzhemilev, Usein M. (2016)

Topoisomerase I and IIa inhibitors

АЛЛОГЕННЫЙ БИОМАТЕРИАЛ – ИНГИБИТОР ФИБРОЗА В ИШЕМИЧЕСКИ ПОВРЕЖДЕННОМ МИОКАРДЕ

Allogeneic biomaterial: a fibrosis inhibitor in ischemic myocardial damage

Лебедева, А.И., Гареев, Е.М., Афанасьев, С.А., Кондратьева, Д.С., Муслимов, С.А., Попов, С.В., Lebedeva, A.I., Gareev, E.M., Afanasiev, S.A., Kondratyeva, D.S., Muslimov, S.A., Popov, S.V. (2023)

Allogeneic biomaterial: a fibrosis inhibitor in ischemic myocardial damage

ИНГИБИРОВАНИЕ ИНВАЗИИ РАКОВЫХ КЛЕТОК И МЕТАСТАЗОВ ПРИ ПОМОЩИ ИНГИБИТОРОВ NF-КАППА-B (INHIBITION OF CANCER CELL INVASION AND METASTASIS BY NF-KAPPA-B INHIBITORS)

INHIBITION OF CANCER CELL INVASION AND METASTASIS BY NF-KAPPA-B INHIBITORS (ИНГИБИРОВАНИЕ ИНВАЗИИ РАКОВЫХ КЛЕТОК И МЕТАСТАЗОВ ПРИ ПОМОЩИ ИНГИБИТОРОВ NF-КАППА-B)

Т. Укаджи, T. Ukaji, Ш. Х. Ганцев, Sh. Kh. Gаntsev, К. Умезава, K. Umezawa (Креативная хирургия и онкология, №3, 2017)

INHIBITION OF CANCER CELL INVASION AND METASTASIS BY NF-KAPPA-B INHIBITORS (ИНГИБИРОВАНИЕ ИНВАЗИИ

Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ

Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ

Sh. Kh. Gantsev, Sh. Kh. Gantsev, Kazuo Umezawa, Kazuo Umezawa (Креативная хирургия и онкология, №1, 2019)

Importance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQ

SYNTHESIS AND TRANSFORMATIONS OF METALLACYCLES. 45. CROSS-CYCLOMAGNESIATION OF 1,2-DIENES IN THE SYNTHESIS OF 5Z, 9Z-DIENOIC ACIDS, EFFICIENT INHIBITORS OF HUMAN TOPOISOMERASE I

D’yakonov, V.A., Dzhemileva, L.U., Makarov, A.A., Mulyukova, A.R., Tuktarova, R.A., Islamov, I.I., Dzhemileva, U.M. (2015)

IN THE SYNTHESIS OF 5Z, 9Z-DIENOIC ACIDS, EFFICIENT INHIBITORS OF HUMAN TOPOISOMERASE I

ROLE OF ALLELIC GENES OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS IN THE RISK OF PEPTIC ULCER DISEASE DEVELOPMENT

Shaymardanova, E.Kh., Nurgalieva, A.Kh., Khidiyatova, I.M., Gabbasova, L.V., Kuramshina, O.A., Kryukova, A.Ya., Sagitov, R.B., Munasipov, F.R., Khusnutdinova, E.Kh. (2016)

(rs2276109) and their tissue inhibitors TIMP2 (rs8179090) and TIMP3 (rs9619311) was carried out in 353

ЭФФЕКТИВНОСТЬ ИНГИБИТОРА ТИРОЗИНКИНАЗ 1-ГО ПОКОЛЕНИЯ (СУНИТИНИБ) В ТЕРАПИИ МЕТАСТАТИЧЕСКОГО ПОЧЕЧНО-КЛЕТОЧНОГО РАКА В АЛЬТЕРНАТИВНЫХ РЕЖИМАХ ДОЗИРОВАНИЯ

EFFICACY OF THE 1ST GENERATION TYROSINE KINASE INHIBITOR SUNITINIB IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN ALTERNATIVE DOSING REGIMENS

МЕНЬШИКОВ, К. В., СУЛТАНБАЕВ, А. В., МУСИН, Ш. И., ИЗМАЙЛОВ, А. A., ЧАЛОВ, В. С., МЕНЬШИКОВА, И. А., СУЛТАНБАЕВА, Н. И., ПОПОВА, Е. В., ЛИПАТОВ, Д. О., MENSHIKOV, K. V., SULTANBAEV, A. V., MUSIN, SH. I., IZMAILOV, A. A., CHALOV, V. S., MENSHIKOVA, I. A., SULTANBAEVA, N. I., POPOVA, E. V., LIPATOV, D. O. (2022)

EFFICACY OF THE 1ST GENERATION TYROSINE KINASE INHIBITOR SUNITINIB IN THE TREATMENT OF METASTATIC

Роль ингибиторов EGFR 2-го поколения в терапии рака легкого в реалиях современной клинической практики

The role of second-generation EGFR inhibitors in lung cancer therapy in the realities of modern clinical practice

ИЗМАЙЛОВ, А.А., НАСРЕТДИНОВ, А.Ф., СУЛТАНБАЕВ, А.В., САКАЕВА, Д.Д., МЕНЬШИКОВ, К.В., СУЛТАНБАЕВА, Н.И., МУСИН, Ш.И., Izmailov, A.A., Nasretdinov, A.F., Sultanbaev, A.V., Sakaeva, D.D., Menshikov, K.V., Sultanbaeva, N.I., Musin, Sh. I. (2021)

Modern third-generation tyrosine kinase inhibitors (TKIs) show amazing results in the treatment

The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study

trial was to evaluate the efficacy and safety of IL-6 receptor inhibitor levilimab (LVL) in subjects

Страница 5 из 20